Oculoselective beta-blockers for treatment of elevated intraocul

Details Oculoselective beta-blockers for treatment of elevated intraocul Oculoselective beta-blockers for treatment of elevated intraocul

1985-08-29

1987-05-12

Garner, Vivian

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

2605011, 514548, 514554, 514652, 514913, 514555, 548215, 558414, 558422, 560240, 560252, 564349, 564351, A61K 3122, C07C 9300, C07C 9306

Patent

active

046650946

ABSTRACT:
Hydroxyalkyl-phenoxy-propan-2-olamines and novel esters thereof are oculoselective .beta.-blockers useful in the treatment of elevated intraocular pressure with little or no effect on the pulmonary or cardiovascular system.

REFERENCES:
patent: 3542872 (1970-11-01), Koppe
patent: 3644469 (1972-02-01), Koppe et al.
patent: 3663607 (1972-05-01), Barrett et al.
patent: 3872147 (1975-03-01), Koppe
patent: 3892799 (1975-07-01), Pinhas
patent: 3930016 (1975-12-01), Berntsson et al.
patent: 4066768 (1978-01-01), Raabe et al.
patent: 4171370 (1979-10-01), Jones et al.
patent: 4450172 (1984-05-01), Yoo
patent: 4515814 (1985-05-01), Wick et al.

Affiliated with

Also associated with

Rating

Oculoselective beta-blockers for treatment of elevated intraocul does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oculoselective beta-blockers for treatment of elevated intraocul, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oculoselective beta-blockers for treatment of elevated intraocul will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1802697